Greater Physiotherapy Exposure Tracks With Less Disability After Heart Failure Admission
In older adults admitted with acute heart failure, hospital days often carry a functional cost that is easy to miss if the focus stays fixed on congestion, blood pressure, and discharge timing. This secondary analysis of a nationwide Japanese registry points in a different direction: more intensive in-hospital physiotherapy was associated with a lower incidence of hospitalisation-associated disability across baseline functional strata.
The cohort was large and clinically frail by design. Among 9448 patients aged 65 years or older, median age 83 years, 3503 developed disability during admission, for an overall rate of 37.1%. The burden is substantial, and it reflects a familiar geriatric pattern in which even a short hospital stay can erode the ability to walk, transfer, or manage self-care. In heart failure, this vulnerability is amplified by bed rest, deconditioning, dyspnea, frailty, and the tendency to postpone mobilization until cardiorespiratory status appears fully stable.
Disability Risk Remained High Across the Registry
Hospitalisation-associated disability was defined as a decline of at least 5 points in the Barthel Index at discharge compared with the prehospital level. That endpoint captures a meaningful bedside consequence: a patient who could previously dress, toilet, or ambulate with relative independence may leave the hospital needing more assistance than before admission. In older heart failure populations, that shift can alter discharge destination, caregiver burden, and the likelihood of another rapid readmission.
Physiotherapy exposure was not treated as a binary event. Investigators examined the number of modalities delivered, the frequency per week, and the amount per week. The modalities were concrete and progressive: basic out-of-bed activity, gait exercise, low-intensity muscle training, aerobic exercise, and resistance training. This matters biologically because immobility accelerates skeletal muscle loss, worsens orthostatic tolerance, and narrows the reserve needed for recovery after acute decompensation. A patient who remains in bed longer than necessary can lose function faster than edema can be mobilized.
More Modalities, More Sessions, Less Functional Decline
Greater physiotherapy implementation was consistently associated with lower HAD incidence. Higher numbers of modalities, greater weekly frequency, and larger overall treatment amounts all tracked with better functional preservation. The pattern held across prehospital Barthel Index subgroups, which suggests that the intervention was not limited to one narrow slice of the older heart failure population.
A particularly interesting signal emerged when the investigators examined effect modification by baseline function. For patients with a prehospital Barthel Index of 60 to 80, modality showed evidence of interaction, with a P value for interaction of .048. For those with a Barthel Index below 60, frequency showed evidence of interaction, with a P value for interaction of .045. Compared with patients whose baseline Barthel Index was at least 85, these findings suggest that the most functionally impaired patients may be the ones who stand to gain most from a broader and more frequent physiotherapy plan.
In practical terms, a low-function patient may need repeated mobility exposure rather than a single therapy touchpoint. Repetition likely helps preserve neuromuscular coordination, reinforces confidence with transfers and ambulation, and limits the downward spiral that begins when patients stop moving because moving has already become difficult. The study does not prove causality, but the physiology is plausible and the signal is consistent with bedside experience.
Baseline Function Shaped the Observed Benefit
The stratified analysis is the most clinically useful part of this registry. Patients who entered the hospital with better function are not the same as those already near the lower edge of independence. A Barthel Index of 85 or higher suggests a more resilient starting point, while a score below 60 indicates substantial preexisting dependence and a much narrower margin for safe inactivity. In those lower-function groups, the association between physiotherapy and reduced disability may reflect the difference between maintaining enough reserve to leave the hospital in a similar state and tipping into a new level of dependence.
The physiologic logic is straightforward. Acute heart failure creates a state in which venous congestion, dyspnea, fatigue, and cautious nursing routines can all reinforce inactivity. Early and repeated movement counters that cycle. Out-of-bed activity reduces time spent in a posture that worsens orthostatic intolerance; gait work preserves transfer ability; low-intensity muscle training and resistance exercise help blunt the loss of lower-extremity strength that underlies many discharge failures in older adults.
What the Registry Can and Cannot Prove
This was a prospective observational study from 96 sites in Japan, not a randomized trial. The registry design means physiotherapy exposure may correlate with factors that also predict better recovery, including staffing, patient selection, illness severity, or institutional rehabilitation culture. Logistic regression can adjust for measured confounders, but it cannot remove all the differences between patients who receive more intensive therapy and those who do not.
Even so, the size of the cohort and the consistency of the association across physiotherapy dimensions make the findings hard to dismiss. The study also speaks to a real-world question that hospital teams face every day: whether more structured mobilization during an acute heart failure admission can protect function rather than merely consume resources. The data suggest that the answer may be yes, especially when therapy is broader in scope and delivered more often in patients with poorer baseline function.
What remains unresolved is the ideal physiotherapy prescription for older patients with acute heart failure. The registry does not establish which combination of modalities is best, how early therapy should begin, or whether certain patients should receive a more aggressive versus a more cautious approach. Future interventional studies will need to define the dosing of rehabilitation with the same precision used for pharmacologic therapy, because preserving mobility is not an optional outcome in this population. It is part of the recovery itself.